The United States has recorded more measles cases in 2026 than in any year since 1991. It has also recorded fewer measles hospitalizations than last year, and no deaths.
Both statements are true, and the tension between them is the most under-examined feature of this outbreak year.
As of July 30, the CDC counted 2,371 confirmed cases across 45 jurisdictions, with 94% outbreak-associated. Hospitalizations stood at roughly 7% of patients, down from 11% in 2025. In absolute terms, 151 people were hospitalized this year through late July compared with 243 across all of 2025. Three people died in 2025, two unvaccinated children in Texas and one unvaccinated adult in New Mexico. None have died in 2026.
That pairing does not settle any argument about whether the national response has been adequate. It complicates the arithmetic on both sides, and it deserves to be read carefully rather than deployed.
Reasons the Rate Could Fall without Anything Improving
The most important caveat is that the hospitalization rate is a ratio, and both parts of it are measured imperfectly.
The denominator is confirmed cases, and confirmed cases undercount infections. Utah state epidemiologist Dr. Leisha Nolen has said modeling and genetic analysis suggest a large outbreak on the Utah-Arizona border could be three to four times larger than the confirmed count. South Carolina's health department has acknowledged that its 997-case total is likely an undercount without being able to say by how much.
If true infections substantially exceed confirmed cases, the real hospitalization rate is lower than 7%. It would also have been lower than 11% last year, and the comparison between the two years only holds if the degree of undercounting is similar in both, which nobody has established.
The numerator has its own problem. Measles hospitalizations are not required to be reported in every state, which means the count of 151 depends on which jurisdictions are reporting outcomes and how completely.
A composition effect may also be at work. Roughly 10% of case-patients aged 5 and under have required hospitalization this year, and about 10% of those aged 20 and older, while only about 3% of those aged 5 to 19 have. A year whose cases skew toward school-age children will produce a lower overall hospitalization rate than a year concentrated in infants and adults, without any change in how sick an individual patient gets.
The Utah Data Show What Hospitalization Actually Involves
Utah published outcome data on its outbreak, which has produced 711 cases over 12 months including 514 in 2026. A chart review of the outbreak was also published in NEJM Evidence.
About 8% of Utah patients required hospitalization. Among those admitted, 90% were unvaccinated. Three of the five hospitalized patients who had been vaccinated had severe immunocompromising conditions.
The clinical detail is where the percentage stops being abstract. About three quarters of hospitalized patients required intravenous fluids. More than 60% needed supplemental oxygen. and 29% developed measles pneumonia, the complication that is the most common cause of measles death in young children.
Roughly one in three hospitalized measles patients developing pneumonia is not a picture of a mild illness that happens to send a few people to hospital. It is a picture of a serious disease whose severe outcomes are concentrated almost entirely among people who were not vaccinated.
That concentration is the finding that both the alarmed and the dismissive readings tend to skip. The absence of deaths in 2026 does not mean measles has become benign. It means that a smaller number of people reached the point where death was a realistic outcome, and that intensive supportive care worked for those who did.
Zero Deaths Is a Statistic with Wide Uncertainty
Measles case fatality in high-income settings is roughly one to three deaths per 1,000 reported cases. At 2,371 cases, the expected number of deaths is small enough that zero and three are both consistent with the same underlying risk.
Put plainly, last year's three deaths and this year's zero may not represent a change in anything. Random variation in a small number of severe outcomes can produce that difference on its own. Reading zero deaths as evidence that the response improved, or reading three deaths as evidence that it failed, both assign more meaning to the number than it can carry.
The comparison also has a timing problem. The year is not over. Cases have been reported continuously and school reopening in August and September is historically the highest-risk transmission window. A death occurring in the autumn would change the 2026 figure and would not indicate that anything about the summer had been misread.
The Numbers That Are Not Ambiguous
Some figures in this data set carry no interpretive difficulty at all.
Ninety-three percent of confirmed measles patients in 2026 were unvaccinated or of unknown vaccination status. National MMR coverage among kindergartners fell to 92.5% in the 2024 to 2025 school year, from 95.2% in 2019 to 2020, below the roughly 95% threshold associated with herd immunity. The Pan American Health Organization is scheduled to review US measles elimination status later this year.
Those three facts describe a susceptibility problem that a favorable hospitalization ratio does not address. A lower share of patients requiring admission tells you something about how sick the people who got measles became. It tells you nothing about how many people remain unprotected.
For a household, the practical takeaway is unchanged by any of this. Two doses of MMR are about 97% effective, and one dose is about 93% effective. The CDC schedule calls for the first dose at 12 through 15 months and the second at 4 through 6 years. Infants as young as 6 months can receive an early dose in outbreak settings, a decision for a pediatrician. Adults unsure of their status can safely receive another dose.
Symptoms include high fever, cough, runny nose and red, watery eyes, followed by a rash beginning on the face. Anyone with possible exposure and these symptoms should call a clinician before going in person. This article is general information and is not a diagnosis.
What to watch is whether the hospitalization share holds as the year continues and cases shift toward school settings, and whether states begin reporting outcomes more uniformly. MedicalDaily will report the weekly CDC figures and the PAHO determination when it is issued.
Frequently Asked Questions
What do the numbers show? The US has 2,371 confirmed measles cases as of July 30, the most since 1991, with about 7% hospitalized compared with 11% in 2025 and no deaths this year.
Does a lower hospitalization rate mean measles is less dangerous? No. Among Utah's hospitalized patients, 29% developed measles pneumonia and more than 60% needed supplemental oxygen.
Why might the rate have fallen? Possible explanations include undercounted cases inflating the denominator, incomplete hospitalization reporting, and a different age distribution of patients this year.
Is zero deaths meaningful? With roughly 2,400 cases, zero and three deaths are both consistent with the same underlying risk. The year is also not finished.
Who is being hospitalized? About 10% of patients aged 5 and under and 10% of those 20 and older, compared with about 3% of those aged 5 to 19. In Utah, 90% of those admitted were unvaccinated.
What has not changed? Ninety-three percent of patients were unvaccinated or of unknown status, and kindergarten MMR coverage has fallen to 92.5% nationally.
What should families do? Confirm that every household member is up to date on MMR. Two doses are about 97% effective.
